Equity Pharmaceuticals Limited
About Equity Pharmaceuticals Limited
Data last updated:
Equity Pharmaceuticals Limited is a public limited company based in Chandigarh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 March 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2012PLC033648. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It was formerly known as Equity Pharmaceutical Limited. It is led by directors including Asif Iqbal Zargar and Tahir Altaf Mir.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 254 Ground Floor Village Sarangpur Chandigarh, Chandigarh, India – 160014.
As per the financials filed for FY 2022, the company reported a revenue of ₹1.98 Cr, a decline of 27% compared to the previous year. For the same year it recorded a net loss of ₹72,465 (net margin -0.4%) and EBITDA of ₹12.99 Lakh (EBITDA margin 6.5%). Revenue has declined at a compounded annual rate (CAGR) of 17% over three years and 10% over five years.
The company has about 13 employees on its provident fund (EPFO) records.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address254 Ground Floor Village Sarangpur Chandigarh, Chandigarh, India – 160014
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Equity Pharmaceuticals Limited
The main business activity of Equity Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Equity Pharmaceuticals Limited FY 2025 filings available
Equity Pharmaceuticals Limited reported revenue of ₹1.98 Cr (down 27% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Equity Pharmaceuticals Limited
Revenue has declined at a compounded annual rate (CAGR) of 10% over five years, including a 27% fall in the latest year. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Equity Pharmaceuticals Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹1.98 Cr | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹12.99 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹72,465 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Equity Pharmaceuticals Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -0.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Equity Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Equity Pharmaceuticals Limited
Equity Pharmaceuticals Limited is audited by RAJESH AGGARWAL & ASSOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAJESH AGGARWAL & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Equity Pharmaceuticals Limited
Equity Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Asif Iqbal Zargar | Director | 19 Mar 2012 | 14 Years 6 Months | Current |
| Tahir Altaf Mir | Director | 19 Mar 2012 | 14 Years 6 Months | Current |
| Zahoor Ahmad Bhat | Director | 19 Mar 2012 | 14 Years 6 Months | Current |
| Javeed Ahmad Bhat | Director | 19 Mar 2012 | 14 Years 6 Months | Current |
Ownership and Shareholding of Equity Pharmaceuticals Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Equity Pharmaceuticals Limited
Equity Pharmaceuticals Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Equity Pharmaceuticals Limited
Equity Pharmaceuticals Limited has a workforce of 13 employees as of Mar 21, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Equity Pharmaceuticals Limited
Equity Pharmaceuticals Limited has 4 board changes on record since 2012: 4 appointments. The latest: Asif Iqbal Zargar was appointed as Director on 19 Mar 2012.
Credit Ratings, Litigation & Regulatory Alerts for Equity Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Equity Pharmaceuticals Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Equity Pharmaceuticals Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Equity Pharmaceuticals Limited
Equity Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Equity Pharmaceuticals Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Equity Pharmaceuticals Limited
Equity Pharmaceuticals is an active public limited company based in Chandigarh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 March 2012 (14+ years old) and is registered under CIN U24232CH2012PLC033648.
Equity Pharmaceuticals reported revenue of ₹1.98 Cr for FY 2022 (down 27% YoY).
Equity Pharmaceuticals has 4 current directors:
- Asif Iqbal Zargar - Director
- Tahir Altaf Mir - Director
- Zahoor Ahmad Bhat - Director
- Javeed Ahmad Bhat - Director
Equity Pharmaceuticals reported a net loss of ₹72,465 (net margin -0.4%) and EBITDA of ₹12.99 Lakh (EBITDA margin 6.5%) for FY 2022, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Equity Pharmaceuticals is -17% over three years and -10% over five years. In the latest year (FY 2022) revenue fell 27%. CAGR is the steady yearly rate that links the first and the last year.
No. Equity Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Equity Pharmaceuticals is U24232CH2012PLC033648. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Equity Pharmaceuticals was incorporated on 19 March 2012, making it 14+ years old. It is registered with the Registrar of Companies, Chandigarh.
Asif Iqbal Zargar was appointed as Director on 19 Mar 2012. Javeed Ahmad Bhat was appointed as Director on 19 Mar 2012. Tahir Altaf Mir was appointed as Director on 19 Mar 2012. Equity Pharmaceuticals has 4 board changes on record in total.
The registered office of Equity Pharmaceuticals is at 254 Ground Floor Village Sarangpur Chandigarh, Chandigarh, India – 160014.